• BorgWarner (NYSE: BWA) to give business update at 10am.
• Burger King (NYSE: BKC) to report Q1 earnings; conference call at 10am.

• Merrill Lynch to host conference call discussing Focus Media's (NASDAQ: FMCN) secondary offering at 11am.
• Yahoo (NASDAQ: YHOO) CEO Jerry Yang, Senior VP Michael Callahan & General Counsel to testify before the House Foreign Affairs Committee on how their company gave false information to Congress relating to their role in a human rights case in China which resulted in a journalist being sent to jail for 10 years.

• Symmetry Medical (NYSE: SMA) to give Q3 business update at 8am.
• Fluor (NYSE: FLR) to report Q3 earnings; conference call at 9:30am.
• Hot Topic (NASDAQ: HOTT) to report October sales at 4pm, American Eagle (NASDAQ: AEO) to report Oct. sales at 5pm.

• Disney (NYSE: DIS) to report Q4 earnings; conference call at 4:30pm.
• CyberSource (NASDAQ: CYBS) to give 2007 guidance at 4:30pm.
• Gap (NYSE: GPS) and Wal-Mart Stores (NYSE: WMT) to report Oct. sales at 8am, Abercrombie & Fitch (NYSE: ANF) to report Oct. sales at 8:15am.

• Halozyme Therapeutics (NASDAQ: HALO) to give business update at 11am.
• Goldcorp (NYSE: GG) to report Q3 earnings; conference call at 1pm.

Market highlights for next week: Yahoo CEO to testify before Congress originally appeared on BloggingStocks on Fri, 02 Nov 2007 15:00:00 EST. Please see our terms for use of feeds.

MOST NOTEWORTHY:

• Halozyme (NASDAQ: HALO) was initiated with a Buy rating and $14 target at Oppenheimer. The firm is positive on Halozyme's prospects for signing additional multi-product Enhanze deals in the next 12 months and the company's expanding internal pipeline.

• Oppenheimer also initiated shares of Rosetta Genomics (NASDAQ: ROSG) with a Buy rating and $11 target, as the firm is positive on Rosetta's intellectual property position in the emerging microRNA field related to the development and commercialization of research, diagnostic and therapeutic products, and other applications.

• Goldman Sachs resumed coverage of U.S. Steel Group (NYSE: X) with a Neutral rating.

• BioFuel Energy (NASDAQ: BIOF) was initiated with a Neutral rating at Cowen, as the firm sees a lack of catalysts until the company's plants under construction come on line in Q108...

• Brightpoint (NASDAQ: CELL) was initiated with an Outperform rating and $18 target at Credit Suisse.

• MasterCard (NYSE: MA) was initiated with a Market Perform rating at Wachovia on valuation.

• Citigroup initiated shares of Signature Bank (NASDAQ: SBNY) with a Buy rating and $39 target and shares of Discover Financial Services (NYSE: DFS) with a Sell rating and $24 target.

• Pacific Growth Equities started shares of Altair Nanotechnologies (NASDAQ: ALTI) with a Neutral rating.

Analyst initiations 7-24-07: CELL, DFS, MA and X originally appeared on BloggingStocks on Tue, 24 Jul 2007 11:11:00 EST. Please see our terms for use of feeds.